Stomach Cancer Trial, Recruiting NCT01915225 Sponsor: National Cancer Institute (NCI) Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT01915225
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 2 years or older (note: children aged 2 to 17 may only participate in the sample collection part if tissue is collected during a surgery that is already being done for medical reasons, and the sample collection — such as blood, urine, or tissue — does not add any extra risk)
  • People who have pre-cancerous conditions, primary tumours, or cancer that has spread to other parts of the body, based on scans, clinical suspicion, blood tests, a known genetic predisposition, or laboratory analysis of tissue — and who need surgery or biopsy as part of their diagnosis, prevention, treatment, or follow-up
  • People who do not have a solid tumour but who are having a diagnostic, preventative, or treatment procedure, and for whom data about surgical safety and outcomes will be collected
  • People whose blood test results and physical health are within acceptable ranges before their biopsy or surgery
  • People who are already planning to have surgery or a biopsy as part of their standard medical care
  • People (or their parent, guardian, or legal representative) who are willing and able to sign a written consent form

Who may not be able to join:

  • There are no listed exclusion criteria for this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jonathan M Hernandez, M.D., National Cancer Institute (NCI)

Phone: (240) 858-7006

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 July 2013
Est. completion
30 June 2035

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Collection of biologic samples from participants undergoing diagnostic or therapeutic interventions for premalignant, primary or metastatic solid tumors for the purpose of identifying novel molecular and biologic therapeutic targets

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov